GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

doi:10.1016/j.jclinepi.2016.01.032

. 2016 Aug:76:89-98.

doi: 10.1016/j.jclinepi.2016.01.032. Epub 2016 Feb 27.

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

Collaborators, Affiliations

Affiliations

¹ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada. Electronic address: schuneh@mcmaster.ca.
² Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Medicine, School of Medicine, University of Missouri-Kansas City, M4-303, 2411 Holmes Street, Kansas City, MO 64108-2792, USA.
³ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada.
⁴ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada.
⁵ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Centro Cochrane Iberoamericano, Instituto de Investigación Biomédica (IIB Sant Pau-CIBERESP), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
⁶ Cochrane Netherlands/Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
⁷ Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Clinical Epidemiology and Biostatistics and Bioinformatics Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room J1b-209, P.O. Box 227001100 DE, Amsterdam, The Netherlands.
⁸ Clinical Epidemiology and Biostatistics and Bioinformatics Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room J1b-209, P.O. Box 227001100 DE, Amsterdam, The Netherlands.
⁹ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad-El-Solh Beirut 1107 2020, Lebanon.
¹⁰ Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Medicine Service and Center for Surgical Medical Acute care Research and Transitions, Department of Medicine, VA Medical Center, 510, 20th Street South, FOT 805B, Birmingham, AL, USA.
¹¹ Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane Germany, Medical Center, University of Freiburg, Berliner Allee 29, 79110 Freiburg, Germany.
¹² Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), S:t Eriksgatan 117, SE-102 33, Stockholm, Sweden & Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Tomtebodav. 18 A, SE-171 77, Stockholm, Sweden.
¹³ Norwegian Knowledge Centre for the Health Services, Boks 7004 Street Olavsplass, N-0130 Oslo, Norway.

PMID: 26931285
DOI: 10.1016/j.jclinepi.2016.01.032

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

Holger J Schünemann et al. J Clin Epidemiol. 2016 Aug.

. 2016 Aug:76:89-98.

doi: 10.1016/j.jclinepi.2016.01.032. Epub 2016 Feb 27.

Authors

Affiliations

¹ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada. Electronic address: schuneh@mcmaster.ca.
² Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Medicine, School of Medicine, University of Missouri-Kansas City, M4-303, 2411 Holmes Street, Kansas City, MO 64108-2792, USA.
³ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada.
⁴ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada.
⁵ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Centro Cochrane Iberoamericano, Instituto de Investigación Biomédica (IIB Sant Pau-CIBERESP), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
⁶ Cochrane Netherlands/Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
⁷ Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Clinical Epidemiology and Biostatistics and Bioinformatics Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room J1b-209, P.O. Box 227001100 DE, Amsterdam, The Netherlands.
⁸ Clinical Epidemiology and Biostatistics and Bioinformatics Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room J1b-209, P.O. Box 227001100 DE, Amsterdam, The Netherlands.
⁹ Department of Clinical Epidemiology and Biostatistics & McGRADE Center, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad-El-Solh Beirut 1107 2020, Lebanon.
¹⁰ Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Medicine Service and Center for Surgical Medical Acute care Research and Transitions, Department of Medicine, VA Medical Center, 510, 20th Street South, FOT 805B, Birmingham, AL, USA.
¹¹ Cochrane GRADEing (Applicability and Recommendations) Methods Group, 1280 Main Street West McMaster University, Hamilton, Ontario L8S 4K1, Canada; Cochrane Germany, Medical Center, University of Freiburg, Berliner Allee 29, 79110 Freiburg, Germany.
¹² Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), S:t Eriksgatan 117, SE-102 33, Stockholm, Sweden & Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Tomtebodav. 18 A, SE-171 77, Stockholm, Sweden.
¹³ Norwegian Knowledge Centre for the Health Services, Boks 7004 Street Olavsplass, N-0130 Oslo, Norway.

PMID: 26931285
DOI: 10.1016/j.jclinepi.2016.01.032

Abstract

Objectives: To describe the grading of recommendations assessment, development and evaluation (GRADE) interactive evidence to decision (EtD) frameworks for tests and test strategies for clinical, public health, or coverage decisions.

Study design and setting: As part of the GRADE Working Group's DECIDE project, we conducted workshops, user testing with systematic review authors, guideline developers and other decision makers, and piloted versions of the EtD framework.

Results: EtD frameworks for tests share the structure, explicitness, and transparency of other EtD frameworks. They require specifying the purpose of the test, linked or related management, and the key outcomes of concern for different test results and subsequent management. The EtD criteria address test accuracy and assessments of the certainty of the additional evidence necessary for decision making. When there is no direct evidence of test effects on patient-important outcomes, formal or informal modeling is needed to estimate effects. We describe the EtD criteria based on examples developed with GRADEpro (www.gradepro.org), GRADE's software that also allows development and dissemination of interactive summary of findings tables.

Conclusion: EtD frameworks for developing recommendations and making decisions about tests lay out the sequential steps in reviewing and assessing the different types of evidence that need to be linked.

Keywords: Decision-making; GRADE; GRADEpro; Guidelines; Recommendations; Summary of findings; Tests.

PubMed Disclaimer

Cited by

Diagnosing acute aortic syndrome: a Canadian clinical practice guideline.
Ohle R, Yan JW, Yadav K, Cournoyer A, Savage DW, Jetty P, Atoui R, Bittira B, Wilson B, Gupta A, Coffey N, Callaway Y, Middaugh J, Ansell D, Rubens F, Bignucolo SJ, Scott TM, McIsaac S, Lang E. Ohle R, et al. CMAJ. 2020 Jul 20;192(29):E832-E843. doi: 10.1503/cmaj.200021. CMAJ. 2020. PMID: 32690558 Free PMC article. No abstract available.
Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines.
El Mikati IK, Morgan RL, Murad MH, Sultan S, Falck-Ytter Y, Mustafa RA. El Mikati IK, et al. Clin Microbiol Infect. 2023 Apr;29(4):424-428. doi: 10.1016/j.cmi.2023.01.020. Epub 2023 Feb 2. Clin Microbiol Infect. 2023. PMID: 36736663 Free PMC article.
Diagnostic performance of hippocampal volumetry in Alzheimer's disease or mild cognitive impairment: a meta-analysis.
Park HY, Suh CH, Heo H, Shim WH, Kim SJ. Park HY, et al. Eur Radiol. 2022 Oct;32(10):6979-6991. doi: 10.1007/s00330-022-08838-9. Epub 2022 May 4. Eur Radiol. 2022. PMID: 35507052
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, Sakr Y, Sanguinetti M, Timsit JF, Bassetti M. Martin-Loeches I, et al. Intensive Care Med. 2019 Jun;45(6):789-805. doi: 10.1007/s00134-019-05599-w. Epub 2019 Mar 25. Intensive Care Med. 2019. PMID: 30911804
Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience.
Pottie K, Kendall CE, Aubry T, Magwood O, Andermann A, Salvalaggio G, Ponka D, Bloch G, Brcic V, Agbata E, Thavorn K, Hannigan T, Bond A, Crouse S, Goel R, Shoemaker E, Wang JZJ, Mott S, Kaur H, Mathew C, Hashmi SS, Saad A, Piggott T, Arya N, Kozloff N, Beder M, Guenter D, Muckle W, Hwang S, Stergiopoulos V, Tugwell P. Pottie K, et al. CMAJ. 2020 Mar 9;192(10):E240-E254. doi: 10.1503/cmaj.190777. CMAJ. 2020. PMID: 32152052 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

Collaborators

Affiliations

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

Authors

Collaborators

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials